$LMNL

Liminal Biosciences Inc

  • NASDAQ/NMS (GLOBAL MARKET)
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

PRICE

$2.95 ▲0.683%

Extented Hours

VOLUME

45,947

DAY RANGE

2.91 - 3

52 WEEK

2.84 - 21.29

Join Discuss about LMNL with like-minded investors

profile
@viking #StockTraders.NET
recently

Upside: -RMED +45% (momentum) -LMNL +44% (momentum following FDA approval for its Biologics License Application for Ryplazim) -USCR +28% (to be acquired by Vulcan Materials for $74.00/shr in cash valued at $1.29B) -QTS +21% (to be acquired by Blackstone at $78.00/shr for a total transaction value of $10B) -BNGO +14% (names Jason Priar as its Chief Commercial Officer) -EVFM +14% (momentum) -MIC +12% (confirms to sell Atlantic Aviation unit for $4.48B in cash and assumed debt and reorganization obligations) -CDXC +11% (ChromaDex and Walmart launch Tru Niagen in 3,800 (from 3K prior) Walmart Stores Across the United States) -GIII +8.1% (earnings, guidance) -BLUE +7.4% (announces the Lifting of FDA Clinical Hold for Sickle Cell Disease and ß-Thalassemia Studies) -VERU +5.0% (announces positive data at ASCO) -BIIB +4.7% (Biogen and Bio-Thera announce positive results from Phase 3 study of BAT1806) -NOVN +2.3% (results from Novan’s Exploratory Studies further demonstrate Antimicrobial Effect of NITRICIL™ Platform Technology with NVN4100 in Companion Animal Health) -KKR +1.1% (MIC confirms to sell Atlantic Aviation unit for $4.48B in cash and assumed debt and reorganization obligations) Downside: -MOSY -12% (files to sell 1.8M shares at $7.15/shr for a total value of $13M) -PIXY -7.3% (files to sell up to 10.1M shares for holders) -WERN -2.0% (hearing cut at Goldman Sachs to Sell from Neutral) -MSTR -1.2% (to incur $284.5M impairment loss in Q2 due to fluctuations in Bitcoin; files to sell $400M of Senior secured 2028 notes)

97 Replies 13 👍 11 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

/*============================================= = Monday June 07, 2021 = =============================================*/ Monday, June 7, 2021 Futures Up/Down % Last Dow 30.00 0.09% 34,772 S&P 500 -4.25 0.10% 4,224 Nasdaq -45.50 0.33% 13,721 U.S. futures are mixed to start the trading week as the Dow rises, S&P little changed and Nasdaq futures slide about 45 points as shares of U.S. tech giants decline after the Group of Seven (G7) advanced economies agreed this weekend to back a minimum global tax rate of at least 15% (watch shares of $AAPL, $AMZN, $FB, $GOOGL). Apple (AAPL) will kick off its annual Worldwide Developer Conference at 1 p.m. ET. In healthcare, all eyes on Biogen ($BIIB) as the company rises ahead of FDA decision on Alzheimer’s drug aducanumab as the FDA is set to decide on whether to approve company’s controversial Alzheimer’s disease drug. This weekend, Treasury Secretary Janet Yellen said President Joe Biden should push forward with his $4 trillion spending plans even if they cause an inflation spike into next year. She also told Bloomberg in an interview that slightly higher interest rates would be a plus. Other than that, a quiet day for economic data. Stocks climbed on Friday as the key May jobs report showed solid gains, boosting confidence in the economic comeback, while for the week, the S&P rose 0.62%, the Dow added 0.66%, the Nasdaq gained 0.48%. Bitcoin and most other top cryptocurrencies fell on Sunday on concerns that there may be a further crackdown on the industry in China and as a report from Goldman Sachs Group Inc. served as a reminder that institutional adoption may be a long process. In Asian markets, The Nikkei Index rose 77 points to settle at 29,020, the Shanghai Index rose 7 points to 3,599, and the Hang Seng Index slipped -130 points to 28,787. In Europe, the German DAX is up about 35 points to 15,725, while the FTSE 100 is up around 20 points to 7,090. Market Closing Prices Yesterday The S&P 500 Index jumped 37.04 points, or 0.88%, to 4,229.89 The Dow Jones Industrial Average rose 179.39 points, or 0.52%, to 34,756.39 The Nasdaq Composite surged 199.99 points, or 1.47%, to 13,814.49 The Russell 2000 Index advanced 7.16 points, or 0.31% to 2,286.41 Events Calendar for Today 3:00 PM EST Consumer Credit for April Earnings Calendar: Earnings Before the Open: $GII Earnings After the Close: $BBCP, $COUP, $HQY, $MRVL, $MTN, $NAPA, $REVG, $SFIX Other Key Events: American Society of Clinical Oncology (ASCO), 6/4-6/8 Deutsche Bank Global Consumer Conference (virtual), 6/7-6/10 Goldman Sachs Travel & Leisure Conference 2021 (virtual), 6/7-6/8 Oppenheimer Virtual Software & Semiconductor Bus Tour, 6/7-6/11 Macro Up/Down Last Nymex -0.39 69.23 Brent -0.43 71.46 Gold -5.90 1,885.70 EUR/USD -0.0015 1.2152 JPY/USD -0.04 109.48 10-Year Note +0.019 1.579% World News The G7 reached a landmark deal on Saturday to squeeze more money out of multinational companies such as Amazon and Google and reduce their incentive to shift profits to low-tax offshore havens. Hundreds of billions of dollars could flow into the coffers of governments left cash-strapped by the COVID-19 pandemic after the Group of Seven (G7) advanced economies agreed to back a minimum global corporate tax rate of at least 15%. Treasury Secretary Janet Yellen said President Joe Biden should push forward with his $4 trillion spending plans even if they trigger inflation that persists into next year and higher interest rates. “If we ended up with a slightly higher interest rate environment it would actually be a plus for society’s point of view and the Fed’s point of view,” Yellen said Sunday in an interview with Bloomberg News Sector News Breakdown Consumer Las Vegas is making a comeback according to Barron’s saying bookings at casino resorts have gone up, but convention and expo business still faces uncertainty after the pandemic. Among REITs, MGM Growth Properties ($MGP) and VICI Properties ($VICI) offer yields above 4%. Two major Las Vegas Strip players are MGM Resorts International ($MGM) and Caesars Entertainment ($CZR). Regional casinos Boyd Gaming ($BYD) and Red Rock Resorts ($RRR), which cater more to the local market, have gained more than MGM and Caesars since the end of last January. Avis Budget Group Inc ($CAR) board approved a $325 mln increase to company’s share repurchase authorization Lordstown Motors ($RIDE) said it received a notice of delinquency for late filing from the Nasdaq Stock Market because it has yet to file its 10-Q for the quarter ended March 31 Reckitt Benckiser Group Plc agreed to sell its Chinese baby-formula business to Primavera Capital Group for $2.2 billion as the company seeks to exit from the struggling sector. Reckitt will retain an 8% stake in the unit and sees net cash proceeds of about $1.3 billion Tesla ($TSLA) CEO Elon Musk told Twitter followers that the Plaid+ trim is “canceled” as the imminent, lower-priced ‘regular’ Plaid model is “just so good.” It’s the quickest production car ever, he claimed Energy, Industrials and Materials Peabody Energy ($BTU) files to say has entered into at market issuance sales agreement to offer and sell up to 12.5 mln shares of common stock Diana Shipping Inc. ($DSX) files for mixed shelf of up to $750 mln TimkenSteel ($TMST) announced it will increase base pricing on all special bar quality products by $50 per ton Trucker rating changes at Goldman Sachs as they upgraded CH Robinson ($CHRW) to Buy from Sell with a $108 price target saying asset-based truckload sector fundamentals are very robust right now with supply tight, demand strong and prices elevated, while the firm downgraded ArcBest (ARCB) to Neutral and Werner ($WERN) to Sell Financials Barron’s said Allegiance Bancshares ($ABTX), PNC Financial Services Group ($PNC), Pinnacle Financial Partners ($PNFP), SVB Financial Group ($SIVB) are banks that operate in regions where growth is booming, and they can benefit from loan growth sooner Realty Income Corp ($O) files mixed securities shelf Essex Property ($ESS) raises low end of core FFO guidance for Q2 and FY21 as now sees Q2 core FFO of $2.92-3.00 (prior: $2.84-3.00) vs. a consensus of $2.98; sees FY21 core FFO of $12.02-12.46 (prior: $11.46-$12.46) vs. $12.23 consensus. Visa ($V) upgraded to Overweight from Neutral at Piper Sandler and up tgt to $260 from $234 Healthcare Biogen ($BIIB) rises ahead of FDA decision on Alzheimer’s drug aducanumab as the FDA is set to decide on whether to approve company’s controversial Alzheimer’s disease drug. If approved, Biogen’s aducanumab would be the first treatment in more than a decade to treat the disease (other companies with Alzheimer treatments include $AVXL, $PRTA, $SAVA) ChromaDex Corp. ($CDXC) announced the launch of its flagship consumer product Tru Niagen(R) in Walmart, available in 3,800 stores across the United States. Walmart is the first major U.S. retailer to bring this well-studied healthy aging nutrient to stores Fate Therapeutics ($FATE) upgraded to Buy from Neutral at H.C. Wainwright Liminal BioSciences ($LMNL) shares jumped post-market Friday after the U.S. FDA approved Ryplazim for the treatment of patients with plasminogen deficiency type 1 (hypoplasminogenia) Iovance Biotherapeutics ($IOVA) announced updated clinical data for lifileucel from Cohort 2 in the C-144-01 clinical study in patients with advanced melanoma. The data were presented in an oral presentation at the ASCO 2021 Annual Meeting Novartis ($NVS) announced Phase 2 primary endpoint data showing investigational iptacopan – a first-in-class, oral, targeted factor B inhibitor – reduced protein in the urine, an increasingly recognized surrogate marker correlating with progression to kidney failure, and showed promise in stabilizing kidney function in patients with IgA nephropathy, or IgAN Technology, Media & Telecom Apple ($AAPL) will debut major software updates for the iPhone and iPad at its developers’ conference this week Software maker PTC ($PTC) is up 60% over the past two years, but it has more upside as it seeks to dominate the Internet of Things, Barron’s says. Autodesk ($ADSK) confirmed that it has submitted a non-binding proposal to acquire all the outstanding shares of common stock of Altium ($ALMFF) for A$38.50 Flextronics ($FLEX) forecasted that the chip shortage disrupting the car industry and the supply of consumer technology products will last until at least mid-2022 – Financial Times reported

95 Replies 6 👍 11 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

/*============================================= = Premarket Prep 06/01/21 = =============================================*/ U.S. stock futures looking higher, tracking gains in Europe and Asia ahead of manufacturing data that will give fresh insights into the economic recovery. S&P futures are looking higher after closing out May with its fourth consecutive monthly advance as investors have grown more confident that rising inflation won’t lead central banks to ease monetary policy measures, pushing major indexes back toward all-time highs in recent weeks. Economic data in the form of manufacturing showed strength in both Europe and Asia overnight with ISM data coming at 10:00 AM later this morning. For the week, the S&P rose 1.17%, the Dow added 0.94%, the Nasdaq gained 2.06%. For the month, the S&P rose 0.55%, the Dow added 1.94%, and the Nasdaq shed 1.53%. Stocks gained on Friday as investors considered new economic data on consumer spending, income and inflation alongside stronger-than-expected data reports from earlier this week. In Asian markets, The Nikkei Index fell -45 points to 28.814, the Shanghai Index rose 9 points to 3,624 and the Hang Seng Index jumped 316 points to 29,468. In Europe, the German DAX is up over 220 points to 15,640, while the FTSE 100 rises over 80 points to top 7,100. Market Closing Prices Yesterday The S&P 500 Index gained 3.23 points, or 0.08%, to 4,204.11 The Dow Jones Industrial Average rose 64.81 points, or 0.19%, to 34,529.45 The Nasdaq Composite climbed 12.46 points, or 0.09%, to 13,748.74 The Russell 2000 Index declined -4.10 points, or 0.18% to 2,268.97 Events Calendar for Today 7:45 AM ET ICSC Weekly Retail Sales 8:55 AM ET Johnson/Redbook Weekly Sales 9:45 AM EST Markit Manufacturing PMI, May-F 10:00 AM EST Construction Spending for April 10:00 AM EST ISM Manufacturing PMI, for May 10:30 AM EST Dallas Fed Manufacturing for May Earnings Calendar: Earnings Before the Open: $GHM, $KIRK Earnings After the Close: $AMBA, $APPS, $HPE, $ITI, $MDLA, $OESX, $ZM Other Key Events: Cowen 49th Annual TMT Conference (virtual), 6/1-6/3 Deutsche Bank FinTech and Info Service Conference (virtual), 6/1-6/2 Goldman Sachs 3rd Asia Spotlight Symposium (virtual), 6/1-6/4 Jefferies Global Healthcare Conference, 6/1-6/3 KeyBanc Capital Markets Industrials & Basic Materials Conference (virtual), 6/1-6/4 William Blair 40th Annual Growth Stock Conference (virtual), 6/1-6/3 OPEC+ June meeting Macro Up/Down Last Nymex 1.78 68.10 Brent 1.39 70.71 Gold 0.15 1,907.00 EUR/USD 0.0001 1.2228 JPY/USD 0.03 109.61 10-Year Note +0.028 1.622% World News China’s factory activity expanded at the fastest pace this year in May as domestic and export demand picked up, as the Caixin/Markit Manufacturing Purchasing Managers’ Index (PMI) rose to 52.0 last month, the highest level since December and inching up from April’s 51.9. China will allow all couples to have a third child, a surprise move aimed at slowing the nation’s declining birthrate as risks to the economy’s long-term prospects mount because of a rapidly aging population OECD releases U.S. economic forecasts in Paris as PCE 2.6% y/y in 2022; 2.9% y/y in 2021; core PCE 2.6% y/y in 2022; 2.5% y/y in 2021; unemployment rate 4.3% y/y in 2022; 5.6% y/y in 2021 Iran and world powers have started what could be their final negotiations to revive a 2015 nuclear accord that limited the Islamic Republic’s atomic activities in return for sanctions relief. The fifth round of talks has begun in Vienna RBA Rate Decision: Leaves cash rate unchanged at 0.1%, leaves 3Y AGB yield target at 0.1%; RBA won’t increase cash rate until actual inflation is sustainably within 2-3% target range which is unlikely to be 2024 at earliest; a pick-up in inflation/wages is expected but likely to be gradual & modest Sector News Breakdown Consumer AMC Entertainment ($AMC) issued to Mudrick Capital Management, 8.5 mln shares of company’s class a common stock for $230.5 mln Nio ($NIO) said it delivered 6,711 vehicles in May, up 95.3% Y/Y and down 5.5% M/M from April delivery of 7,102 vehicles. Xpeng Inc ($XPEV) said May deliveries jump nearly sixfold as May vehicle deliveries surged 483% to 5,686 units, spurred by record-high demand for XPEV’s P7 sedan Krispy Kreme has filed a Registration Statement on Form S-1 with the SEC relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined Macau’s gaming bureau reported May gross revenue from games of fortune in the region increased 492.2% year-over-year to 10.445B patacas (watch shares of $WYNN, $MLCO, $MGM) Planet Fitness ($PLNT) shares stock could drop 50% after a stunning recovery according to Barron’s as growth slows and the market becomes saturated. Article notes Teton Fund Management, which has shorted the stock, says millions of members will never return to a gym. Dollar General ($DG) and Dollar Tree ($DLTR) reported fiscal-first-quarter results before the bell on Thursday, and both beat analysts’ expectations-but that’s where the similarities end, according to Barron’s. DLTR warned freight costs could have a big impact on earnings, the latest indication that Dollar General is the stronger operator-and that doesn’t look set to change anytime soon For airlines, the Transportation Security Administration (TSA) reported that it screened almost 1.96 million people at airports, compared with 1.85 million on Thursday. That’s the most since March 7, 2020, when the COVID-19 pandemic was in its early stages Energy, Industrials and Materials Oil prices are higher by over 2% (WTI crude $68 per barrel and Brent tops $70) as the latest OPEC+ gathering takes place via videoconference today. OPEC+ decided in April to return 2.1M barrels per day to the market from May to July, anticipating rising global demand. Since the announcement, the crude price has risen from $60 toward the $70 level Exxon Mobil Corp ($XOM) rises along with Equinor EQNR and Petrogal Brasil says they will proceed with an $8 bln development of Brazil’s Bacalhau oil discovery Exxon ($XOM) suffered a setback this week when it lost at least two board seats to the upstart activist Engine No. 1, but the defeat could move the oil giant forward to benefit both the company and the shareholders, according to Barron’s Virgin Galactic ($SPCE) filed a shelf registration for $1 billion of mixed securities, plus 2.7m shares issuable upon the exercise of previously sold warrants Financials American Financial ($AFG) declares special dividend of $14 per share after announces closing of the sale of its annuity businesses and declares special dividend Healthcare Liminal BioSciences Inc. ($LMNL) said it has decided to stop its plans to move fezagepras into a Phase II clinical study in Idiopathic Pulmonary Fibrosis and a phase Ia/IIb study in Hypertriglyceridemia, as it evaluates the impact of the PK data profile observed in the on-going study. Forte Biosciences ($FBRX) files $300M mixed securities shelf Aeglea BioTherapeutics ($AGLE) files to sell 19.02M shares of common stock for holders Technology, Media & Telecom Cloudera ($CLDR) entered into a definitive agreement to be acquired by affiliates of Clayton, Dubilier & Rice and KKR ($KKR) in an all-cash transaction valued at approximately $5.3B (confirming reports overnight by the WSJ). Cloudera shareholders will receive $16.00 in cash per share, representing a 24% premium to the closing price as of May 28, 2021 – confirms overnight WSJ https://on.wsj.com/3uCAZ0g RingCentral ($RNG) team up with Deutsche Telekom ($DTEGY) to transform business communications for customers of all sizes. The chip shortage is creating an opportunity for two stocks according to Barron’s, Applied Materials ($AMAT) and Lam Research ($LRCX) saying both trade at about 20x earnings estimates for the next 12 months, lower than the multiples of S&P 500 Index and the PHLX semiconductor Index. SemiLEDs ($LEDS) files $30M mixed securities shelf

100 Replies 10 👍 8 🔥

profile
@Neptune5045 #StockTraders.NET
recently

If $LMNL turns g/r i'm gna swing it

108 Replies 12 👍 12 🔥

profile
@FillTheGapToZero #StockTraders.NET
recently

$LMNL wow..

120 Replies 6 👍 11 🔥

profile
@FillTheGapToZero #StockTraders.NET
recently

$LMNL I guess that $1 locate would’ve been worth it hmm

133 Replies 13 👍 13 🔥

profile
@FillTheGapToZero #StockTraders.NET
recently

anyone got locates for LMNL? mine is more than a buck per share

124 Replies 9 👍 13 🔥

profile
@Neptune5045 #StockTraders.NET
recently

Also $KZIA $ADMA worth watching > @Neptune5045 said: $SONN $LMNL $KMDA familiar names

41 Replies 8 👍 12 🔥

profile
@Neptune5045 #StockTraders.NET
recently

$SONN $LMNL $KMDA familiar names

67 Replies 15 👍 12 🔥

Key Metrics

Market Cap

87.74 M

Beta

0.43

Avg. Volume

198.27 K

Shares Outstanding

29.94 M

Yield

0%

Public Float

0

Next Earnings Date

2021-08-09

Next Dividend Date

Company Information

Liminal BioSciences is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases of high unmet medical need, primarily related to fibrosis, including respiratory, liver and kidney diseases. Liminal BioSciences has a deep understanding of certain biological targets and pathways that have been implicated in the fibrotic process, including fatty acid receptors such as FFAR1, G-protein-coupled receptor 84 (GPR84), and peroxisome proliferator-activated receptors (PPARs). Our lead small molecule product candidate, fezagepras (PBI-4050), has entered a Phase 1 clinical trial in Q4-2020 in the UK to evaluate multiple ascending doses in normal healthy volunteers, at daily dose exposures higher than those evaluated in our previously completed Phase 2 clinical trials. Fezagepras is expected to be further evaluated in a global Phase 2b clinical trial in patients with idiopathic pulmonary fibrosis (IPF) anticipated to be initiated in H2-2021. In addition, we expect to initiate a Phase 1b/2a clinical trial of fezagepras, for patients with high triglyceride levels (hypertriglyceridemia) in H2-2021. Fezagepras has previously been granted Orphan Drug Designation by the FDA and the European Medical Agency (EMA) for the treatment of IPF. The treatment has also received a Promising Innovative Medicines (PIM) designation by the Medicines and Healthcare products Regulatory Agency (MHRA) for IPF and Alström syndrome.

CEO: Kenneth Galbraith

Website:

HQ: 440 Boulevard Armand Laval, H7V 4B4 Quebec

Related News

  • Kwhen Finance

    Liminal Biosciences Inc Shares Close the Week 25.8% Higher - Weekly Wrap

    30 Apr 2021, 22:30
  • Kwhen Finance

    Liminal BioSciences Inc. Shares Close the Week 20.7% Lower - Weekly Wrap

    26 Feb 2021, 22:30
  • Kwhen Finance

    Liminal BioSciences Inc. Shares Close the Week 31.2% Higher - Weekly Wrap

    15 Jan 2021, 22:30